My Bibliography

select

Pollock NI, Grandis JR. HER2 as a therapeutic target in head and neck squamous cell carcinoma. Clin Cancer Res. 2015 Feb 1;21(3):526-33. doi: 10.1158/1078-0432.CCR-14-1432. Epub 2014 Nov 25. Review. PubMed PMID: 25424855; PubMed Central PMCID: PMC4315724.

select

Sen M, Pollock NI, Black J, DeGrave KA, Wheeler S, Freilino ML, Joyce S, Lui VW, Zeng Y, Chiosea SI, Grandis JR. JAK kinase inhibition abrogates STAT3 activation and head and neck squamous cell carcinoma tumor growth. Neoplasia. 2015 Mar;17(3):256-64. doi: 10.1016/j.neo.2015.01.003. PubMed PMID: 25810010; PubMed Central PMCID: PMC4372647.

select

Pollock NI, Wang L, Wallweber G, Gooding WE, Huang W, Chenna A, Winslow J, Sen M, DeGrave KA, Li H, Zeng Y, Grandis JR. Increased Expression of HER2, HER3, and HER2:HER3 Heterodimers in HPV-Positive HNSCC Using a Novel Proximity-Based Assay: Implications for Targeted Therapies. Clin Cancer Res. 2015 Oct 15;21(20):4597-606. doi: 10.1158/1078-0432.CCR-14-3338. Epub 2015 Jul 2. PubMed PMID: 26138066; PubMed Central PMCID: PMC4609280.

select

LaPorte MG, Wang Z, Colombo R, Garzan A, Peshkov VA, Liang M, Johnston PA, Schurdak ME, Sen M, Camarco DP, Hua Y, Pollock NI, Lazo JS, Grandis JR, Wipf P, Huryn DM. Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors. Bioorg Med Chem Lett. 2016 Aug 1;26(15):3581-5. doi: 10.1016/j.bmcl.2016.06.017. Epub 2016 Jun 9. PubMed PMID: 27381083; PubMed Central PMCID: PMC4964800.

select

Belfer I, Pollock NI, Martin JL, Lim KG, De La Cruz C, Van Londen G, Nunziato-Virga SR, Stranieri K, Brufsky AM, Wang H. Effect of gastroretentive gabapentin (Gralise) on postmastectomy pain syndrome: a proof-of-principle open-label study. Pain Rep. 2017 May;2(3):e596. doi: 10.1097/PR9.0000000000000596. eCollection 2017 May. PubMed PMID: 29392212; PubMed Central PMCID: PMC5741302.

select

Sen M, Johnston PA, Pollock NI, DeGrave K, Joyce SC, Freilino ML, Hua Y, Camarco DP, Close DA, Huryn DM, Wipf P, Grandis JR. Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines. J Chem Biol. 2017 Jul;10(3):129-141. doi: 10.1007/s12154-017-0169-9. eCollection 2017 Jul. PubMed PMID: 28684999; PubMed Central PMCID: PMC5480263.

select

Ekambaram P, Lee JL, Hubel NE, Hu D, Yerneni S, Campbell PG, Pollock N, Klei LR, Concel VJ, Delekta PC, Chinnaiyan AM, Tomlins SA, Rhodes DR, Priedigkeit N, Lee AV, Oesterreich S, McAllister-Lucas LM, Lucas PC. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer. Cancer Res. 2018 Mar 1;78(5):1225-1240. doi: 10.1158/0008-5472.CAN-17-1089. Epub 2017 Dec 19. PubMed PMID: 29259013; PubMed Central PMCID: PMC6436094.

select

Pollock NI, Cohen LE. Growth Hormone Deficiency and Treatment in Childhood Cancer Survivors. Front Endocrinol (Lausanne). 2021;12:745932. doi: 10.3389/fendo.2021.745932. eCollection 2021. Review. PubMed PMID: 34745010; PubMed Central PMCID: PMC8569790.

select

Pollock NI, Bradford VR, Hambrick HR, O'Donnell KA. Facilitating chalk talks via visual teaching tools. Med Educ. 2022 May;56(5):571-572. doi: 10.1111/medu.14762. Epub 2022 Mar 1. PubMed PMID: 35230723.

select

Pollock NI, Flamand Y, Zhu J, Millington K, Stevenson K, Silverman LB, Vrooman LM, Cohen LE. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration. Pediatr Blood Cancer. 2022 Jul;69(7):e29505. doi: 10.1002/pbc.29505. Epub 2021 Dec 21. PubMed PMID: 34931744; PubMed Central PMCID: PMC9133208.

select

Pollock NI, Song M, Wolf AJ, Li Y, Hawkes CP, Motamedi N, Denburg MR, Mostoufi-Moab S. Exploring height outcomes with adjuvant aromatase inhibition in growth hormone-deficient male survivors of childhood cancer. Pediatr Blood Cancer. 2024 Aug;71(8):e31117. doi: 10.1002/pbc.31117. Epub 2024 May 28. PubMed PMID: 38804882; PubMed Central PMCID: PMC11294979.